Literature DB >> 1874894

High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies.

R W Milne1, R L Nation, G D Reynolds, A A Somogyi, J T Van Crugten.   

Abstract

Improvements to previously reported methods for the determination of morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) in human plasma are described. The improved methods involve the use of a solid-phase extraction cartridge and a chromatographic system which uses paired-ion reversed-phase high-performance liquid chromatography with a radially compressed column. Only one cartridge is used to prepare each sample for chromatography and each cartridge may be used for at least fourteen 1-ml plasma samples. The recovery is greater than 85%. The improvements to the method of sample pretreatment and in the chromatographic conditions have allowed determination of morphine, M3G and M6G in human plasma down to 13.3 nmol/l (coefficient of variation = 9.3%), 108 nmol/l (6.6%) and 41 nmol/l (6.7%), respectively, using ultraviolet detection alone. It was shown that all three compounds were stable in plasma for up to 101 weeks when stored at -20 degrees C.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874894     DOI: 10.1016/0378-4347(91)80410-e

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

1.  Blood-brain distribution of morphine-6-glucuronide in sheep.

Authors:  H H Villesen; D J R Foster; R N Upton; L L Christrup; A A Somogyi; A Martinez; C Grant
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

2.  Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics.

Authors:  Andrew A Somogyi; Mie Larsen; Reza M Abadi; Jaroon Jittiwutikarn; Robert Ali; Jason M White
Journal:  Br J Clin Pharmacol       Date:  2008-11       Impact factor: 4.335

3.  Evaluation of a method for simultaneous quantification of codeine, dihydrocodeine, morphine, and 6-monoacetylmorphine in serum, blood, and postmortem blood.

Authors:  F Musshoff; T Daldrup
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

4.  The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.

Authors:  R W Milne; R L Nation; A A Somogyi; F Bochner; W M Griggs
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

5.  Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.

Authors:  Jaroon Jittiwutikarn; Robert Ali; Jason M White; Felix Bochner; Andrew A Somogyi; David J R Foster
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

6.  Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.

Authors:  Glynn A Morrish; David J R Foster; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

7.  Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.

Authors:  A A Somogyi; R L Nation; C Olweny; P Tsirgiotis; J van Crugten; R W Milne; J F Cleary; C Danz; F Bochner
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.